Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction oxaliplatin + 5-fluorouracil chemotherapy followed by preoperative chemoradiation vs preoperative chemoradiation alone in advanced rectal adenocarcinoma
2006-006646-34Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Mar 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxaliplatin and fluorouracil in rectal adenocarcinoma (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Pathologic tumor stage pT0-1. Started Mar 2007; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on 2006-006646-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006646-34.